Evidence map›Paper›PMID 32634590›Full record

ArticleTranslational research : the journal of laboratory and clinical medicine2020

IL-10-producing NK cells exacerbate sublethal Streptococcus pneumoniae infection in the lung.

Sarah E Clark, Rebecca L Schmidt, Elizabeth R Aguilera, Laurel L Lenz

Open access · greenAbstract read
In one paragraph

Article in Translational research : the journal of laboratory and clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. The gut microbiota in cancer immunity and immunotherapy.Cellular & molecular immunology · 2025
    Review
  4. Article
  5. Review
  6. Leukocyte kinetics and bacterial clearance duringAmerican journal of physiology. Lung cellular and molecular physiology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Frontiers in microbiology · 2021
    Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sarah E ClarkDepartment of Otolaryngology, University of Colorado School of Medicine, Aurora, Colorado. Electronic address: sarah.e.clark@cuanschutz.edu.
Rebecca L SchmidtDepartment of Biomedical Sciences, National Jewish Health, Denver, Colorado; Department of Biology and Chemistry, Upper Iowa University, Fayette, Iowa.
Elizabeth R AguileraDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado.
Laurel L LenzDepartment of Biomedical Sciences, National Jewish Health, Denver, Colorado; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado.
National Jewish Health · USUniversity of Colorado Denver · US

Funding

Immune Modulation by Bacterial AutolysinsR01AI065638 · NIAID · UNIVERSITY OF COLORADO DENVER · PI LENZ, LAUREL L · 2006 to 2016
$3.8M
NK cell IL-10 production during bacterial infectionsR01AI131662 · NIAID · UNIVERSITY OF COLORADO DENVER · PI LENZ, LAUREL L · 2017 to 2021
$2.9M
Myeloid cell IFNGR regulation in persistent viral and secondary bacterial infectionsR21AI140499 · NIAID · UNIVERSITY OF COLORADO DENVER · PI LENZ, LAUREL L · 2018 to 2019
$420k
Bacterial-driven immune suppression in the lungK22AI143922 · NIAID · UNIVERSITY OF COLORADO DENVER · PI CLARK, SARAH E · 2019 to 2021
$310k
NIAID NIH HHS K22 AI143922NIAID NIH HHS R01 AI065638NIAID NIH HHS R01 AI131662NIAID NIH HHS R21 AI140499
6 · The paper itself

Abstract

Lung inflammation is tightly controlled to balance microbial clearance with the tissue damage that accompanies this response. Bacterial pathogens including Streptococcus pneumoniae (S. pneumoniae) modulate immune regulation by promoting secretion of the anti-inflammatory cytokine IL-10. The important cellular sources of IL-10 that impact protection against different bacterial infections are not well characterized. We find that S. pneumoniaeactivates IL-10 secretion from natural killer (NK) cells in the lung, which restrict host protection in a mouse model of sublethal infection. Direct transfer of wild-type NK cells into the lungs of IL-10-deficient mice drives bacterial expansion, identifying NK cells as a critical source of IL-10 promoting S. pneumoniae infection. The S. pneumoniae virulence protein Spr1875 was found to elicit NK cell IL-10 production in purified cells and in the lungs of live animals. These findings reveal therapeutic targets to combat bacterial-driven immune regulation in the lung.

Indexed as

AnimalsBacterial VaccinesFemaleImmunity, InnateInterleukin-10Killer Cells, NaturalLung DiseasesMaleMiceMice, Inbred C57BLStreptococcal InfectionsStreptococcus pneumoniaeBacterial VaccinesIL10 protein, mouseInterleukin-10

Identifiers

PMID32634590
PMCPMC7572800
OpenAlexW3039973310

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.